Search Tag: liver cancer treatment

2025 28 Mar

  Hepatocellular carcinoma (HCC) remains a formidable global health challenge, ranking among the leading causes of cancer-related deaths. The latest updates to the European Association for the Study of the Liver (EASL) Clinical Practice Guidelines reflect significant advances in HCC prevention, diagnosis and treatment. As medical science progresses,...Read more

2024 10 Jul

  Combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA) is a rare and complex subtype of primary liver cancer (PLC), characterised by the presence of both hepatocytic and biliary components. Its incidence ranges from 0.4% to 14.2% among PLCs, and its prognosis and treatment have been contentious due to its rarity and histologic heterogeneity....Read more

2024 10 Jul

  Combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA) is a rare and complex subtype of primary liver cancer (PLC), characterised by the presence of both hepatocytic and biliary components. Its incidence ranges from 0.4% to 14.2% among PLCs, and its prognosis and treatment have been contentious due to its rarity and histologic heterogeneity....Read more